+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alofisel"

Alofisel - Product Thumbnail Image

Alofisel

  • Report
  • August 2018
  • 21 Pages
  • Global
From
Crohn's Disease Forecast and Market Analysis to 2026 - Product Thumbnail Image

Crohn's Disease Forecast and Market Analysis to 2026

  • Report
  • August 2018
  • 679 Pages
  • Global
From
Crohn's Disease: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Crohn's Disease: Dynamic Market Forecast to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Remicade - Product Thumbnail Image

Remicade

  • Report
  • August 2018
  • 86 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Alofisel is a type of immune disorder drug used to treat Crohn's disease. It is a biologic therapy, meaning it is made from living cells and is designed to target specific parts of the immune system. Alofisel works by blocking the action of a protein called tumor necrosis factor (TNF), which is involved in inflammation. This helps to reduce inflammation in the digestive tract, which can help to improve symptoms of Crohn's disease. Alofisel is administered as an injection under the skin, and is typically used in combination with other medications. The Alofisel market is made up of a number of companies that produce and distribute the drug. These include Takeda Pharmaceuticals, AbbVie, and Janssen Biotech. Other companies involved in the market include Merck, Pfizer, and UCB. These companies are involved in the research, development, and marketing of Alofisel, as well as the production and distribution of the drug. Show Less Read more